News

April 26, 2022
Medical Research

AMRA Medical’s MRI-based body composition measurements used in Lilly’s SURPASS-3 tirzepatide sub-study

Eli Lilly and Company assessed the impact of tirzepatide, an investigational therapy for the treatment of type 2 diabetes, on liver fat, visceral fat,…
Read More
March 24, 2022
Medical Research

AMRA Webinar: The Patient Experience Using MRI in DMD Clinical Trials – “Shed Light Through MRI”

Join us – with patients, industry leaders and a patient advocacy group to learn how to implement a magnetic resonance imaging (MRI) study designed…
Read More
March 14, 2022
Medical Research

AMRA Medical, Daiichi Sankyo and NCNP joint MRI-based muscle research accepted for poster presentation at 2022 MDA Conference

LINKÖPING, Sweden; March 14, 2022—AMRA’s recent research, performed in collaboration with Daiichi Sankyo and the National Center of Neurology and Psychiatry (NCNP) in Japan,…
Read More
February 23, 2022
Medical Device

AMRA Medical’s MRI-Based Fat & Muscle Assessment Technology Approved for Clinical Use in US and Canada

LINKÖPING, Sweden; February 23, 2022—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research…
Read More
February 14, 2022
Medical Research

AMRA Medical’s MRI data provide a unique opportunity for Pfizer’s GWAS

LINKÖPING, Sweden; February 14, 2022—One of the goals of AMRA’s collaboration with Pfizer and UK Biobank is to help identify and validate noninvasive biomarkers…
Read More
December 21, 2021

Warm Season’s Greetings from the AMRA Team

Dear Friends, The AMRA Team is wishing you uplifted Happy Holidays filled with joy and warmth, and a prosperous Happy New Year! AMRA shared…
Read More
December 21, 2021

AMRA Medical secures $5 million funding agreement with growth debt investor Kreos Capital

LINKÖPING, Sweden; December 21, 2021—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research…
Read More
December 7, 2021
Medical Device

AMRA Medical’s MRI-Based Muscle Assessment Technology Receives FDA 510(k) Clearance

LINKÖPING, Sweden; December 7, 2021—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis, announced today that the AMRA® MAsS…
Read More
December 2, 2021
Medical Device

AMRA Medical’s MRI-Based Muscle Assessment Technology Approved for Clinical Use in Canada

LINKÖPING, Sweden; December 2, 2021 — AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and…
Read More
November 24, 2021
Medical Research

AMRA Medical Introduces Paradigm-shifting MRI Analysis Services at RSNA 2021

LINKÖPING, Sweden; November 24, 2021 – AMRA Medical will introduce two high-precision magnetic resonance imaging (MRI) analysis services for assessing body composition and muscle…
Read More

© 2022 AMRA Medical AB

By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
Accept & Close

Book a Meeting